Mind Medicine Changes Ticker to DFTX from MNMD
ByAinvest
Tuesday, Jan 13, 2026 11:16 am ET1min read
MNMD--
Mind Medicine Inc. will change its ticker symbol from MNMD to DFTX. The company is a clinical-stage biopharmaceutical firm focused on developing treatments for brain health disorders, including MM-120 and MM-402. MM-120 is being studied for generalized anxiety disorder and attention deficit hyperactivity disorder, while MM-402 is being developed for autism spectrum disorder.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet